Immunoassay Market was valued at USD 30.42 Bn. in 2023 and is expected to reach USD 47.49 Bn. at a CAGR of 6.57% during the forecast period 2024-3030.Immunoassay Market Introduction and Overview:
Immunoassays are bio analytical methods in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Immunoassays have been widely used in many important areas of pharmaceutical analysis such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetics and bioequivalence studies in drug discovery and pharmaceutical industries. The importance and widespread of immunoassay methods in the pharmaceutical analysis are attributed to their inherent specificity, high-throughput, and high sensitivity for the analysis of the wide range of analytes in biological samples. Recent improvements are achieved in the field of immunoassay development for the purposes of pharmaceutical analysis.To know about the Research Methodology :- Request Free Sample Report The prevalence and incidence of cancer cases are dramatically increasing globally, thus the application of immunoassay for early diagnosis and monitoring of cancer is growing gradually. According to American Cancer Society, lung cancer is one of the most common forms of cancer. In 2022, nearly 2.09 million people across the globe were living with lung cancer, and according to the WHO, this number is increase by 2.27 million in 2022. Immunoassays have been one of the fast-growing clinical diagnostics technologies over the years. The technological advancements in immunoassays driven by the need for early detection of diseases have supported their adoption over the years, and hence have supported the immunoassay market growth.Important advances have been made in the design of immunochemical approaches that allow small molecules, such as drugs, metabolites, and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages are previously seen only with large molecular analytes. The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Immunoassy Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.
Immunoassay Market Segment Analysis
Based on Type, Radio immunoassays have wide applications in cancer detection, blood screening for hepatitis, diagnosis of ulcers, and narcotics detection. These assays are capable of the quantification of very small concentrations of antigens from small volumes of samples with the help of radioisotopes, such as iodine-125 and iodine-131. The growth in this immunoassay market is primarily driven by the increasing prevalence of cancer across the globe and the resultant increase in suitable diagnostic technologies. However, these assays are relatively high-cost assays and have potential health hazards owing to the use of radioactive antigens. This, along with additional expenses towards maintaining radiation safety and disposal protocols limit their wide-scale use. Owing to these, radioimmunoassay is increasingly being replaced by EIAs and CLIAs, which is expected to hamper the growth of the radioimmunoassay market over the coming years. Endocrine disorders have shown significant growth in recent years. Healthcare providers have started using immunoassay machines for the same. The endocrinology segment is expected to grow at a CAGR of 6.5% by 2029. Endocrinology tests have a wide range of applications, which include immunoassay analyzer testing, anti-TSH receptors testing, fertility testing, and women’s health testing. Such widespread applications are helping the segment expand at a faster pace, thereby growing the market.Regional Analysis
The immunoassay market of North America is expected to dominate the market accounting for nearly 40% of the total market share and registering a CAGR of 6.0% in the forecast period. Growing mergers & acquisitions are observed among in-vitro diagnostic and life sciences players in North America. This is anticipated to largely propel the region’s growth in the future. Key market players are strengthening their product portfolio by venturing into various medical specialty domains. Asia-Pacific is expected to emerge as the fastest-growing region, at a CAGR of 7.0% in the forecast period. This growth is attributed to the high prevalence and incidence rate of chronic and infectious diseases, which has increased per capita healthcare expenditure. Additionally, intensifying competition among diagnostic laboratories and hospitals and subsequent differentiation of products is expected to leverage demand for high-quality immunoassay analyzers, reagents and kits in the Asia-Pacific market.Immunoassay Industry Ecosystem
Immunoassay Market Scope : Inquire before Buying
Global Immunoassay Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 30.42 Bn Forecast Period 2024 to 2030 CAGR: 6.57% Market Size in 2030: USD 47.49 Bn Segments Covered: by Type Radioimmunoassay (RIA) Enzyme Immunoassays (EIA) Fluoroimmnoassay (FIA) Chemiluminescence Immunoassay (CLIA) Others by Application Disease Diagnosis Therapeutic Drug Monitoring Drug Discovery Clinical Chemistry Hematology Others by End Users Hospitals Pharma & Biotech Companies Clinical Laboratories Others Immunoassay Market ,by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key players
1. Siemens Healthineers 2. Becton 3. Dickinson & Company 4. BioMérieux 5. Abbott laboratories 6. Roche Diagnostics 7. Danaher Corporation 8. Ortho Clinical Diagnostics 9. Sysmex Corporation 10. Thermo Fisher Scientific, Inc. 11. Quidel Corporation 12. Agilent Technologies 13. PerkinElmer 14. Mindray 15. DiaSorinFrequently Asked Questions:
1. Which region has the largest share in the Global Immunoassay Market? Ans: North America held the largest market share in 2023 in the global immunoassay market. 2. What is the growth rate of Global Immunoassay Market? Ans: The Global Immunoassay Market is growing at a CAGR of 6.57% during the forecasting period 2024-2030. 3. What is the scope of the Global Immunoassay market report? Ans: The Global Immunoassay Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in the Global Immunoassay market? Ans: The important key players in the Global Immunoassay Market are – Siemens Healthineers, Becton, Dickinson & Company, BioMérieux, Abbott Laboratories, Roche Diagnostics, Danaher Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Thermo Fisher Scientific, Inc., Quidel Corporation, Agilent Technologies, PerkinElmer, Mindray, and DiaSorin. 5. What is the forecasting period of the global immunoassay market market? Ans: The Global Immunoassay Market is studied from 2023 to 2030.
1. Immunoassay Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Immunoassay Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Company Location 2.5.3. Product Segment 2.5.4. End-user Segment 2.5.5. Revenue (2023) 2.5.6. Growth Rate (Y-O-Y in %) 2.5.7. Key Development 2.5.8. Market Share 2.6. Industry Ecosystem Analysis 2.6.1. Role of Key Players in the Ecosystem 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Consolidation of the Market 2.8.1. Strategic Initiatives and Developments 2.8.2. Mergers and Acquisitions 2.8.3. Collaborations and Partnerships 2.8.4. Product Launches and Innovations 3. Immunoassay Market: Dynamics 3.1. Immunoassay Market Trends 3.2. Immunoassay Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape 3.6.1. Regulatory Bodies, Government Agencies, and Other Organizations 3.6.2. Regulatory Framework by Region 4. Immunoassay Market: Global Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 4.1. Immunoassay Market Size and Forecast, by Type (2023-2030) 4.1.1. Radioimmunoassay (RIA) 4.1.2. Enzyme Immunoassays (EIA) 4.1.3. Fluoroimmnoassay (FIA) 4.1.4. Chemiluminescence Immunoassay (CLIA) 4.1.5. Others 4.2. Immunoassay Market Size and Forecast, by Application (2023-2030) 4.2.1. Disease Diagnosis 4.2.2. Therapeutic Drug Monitoring 4.2.3. Drug Discovery 4.2.4. Clinical Chemistry 4.2.5. Hematology 4.2.6. Others 4.3. Immunoassay Market Size and Forecast, by End User (2023-2030) 4.3.1. Hospitals 4.3.2. Pharma & Biotech Companies 4.3.3. Clinical Laboratories 4.3.4. Others 4.4. Immunoassay Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Immunoassay Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 5.1. North America Immunoassay Market Size and Forecast, by Type (2023-2030) 5.1.1. Radioimmunoassay (RIA) 5.1.2. Enzyme Immunoassays (EIA) 5.1.3. Fluoroimmnoassay (FIA) 5.1.4. Chemiluminescence Immunoassay (CLIA) 5.1.5. Others 5.2. North America Immunoassay Market Size and Forecast, by Application (2023-2030) 5.2.1. Disease Diagnosis 5.2.2. Therapeutic Drug Monitoring 5.2.3. Drug Discovery 5.2.4. Clinical Chemistry 5.2.5. Hematology 5.2.6. Others 5.3. North America Immunoassay Market Size and Forecast, by End User (2023-2030) 5.3.1. Hospitals 5.3.2. Pharma & Biotech Companies 5.3.3. Clinical Laboratories 5.3.4. Others 5.4. North America Immunoassay Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Immunoassay Market Size and Forecast, by Type (2023-2030) 5.4.1.1.1. Radioimmunoassay (RIA) 5.4.1.1.2. Enzyme Immunoassays (EIA) 5.4.1.1.3. Fluoroimmnoassay (FIA) 5.4.1.1.4. Chemiluminescence Immunoassay (CLIA) 5.4.1.1.5. Others 5.4.1.2. United States Immunoassay Market Size and Forecast, by Application (2023-2030) 5.4.1.2.1. Disease Diagnosis 5.4.1.2.2. Therapeutic Drug Monitoring 5.4.1.2.3. Drug Discovery 5.4.1.2.4. Clinical Chemistry 5.4.1.2.5. Hematology 5.4.1.2.6. Others 5.4.1.3. United States Immunoassay Market Size and Forecast, by End User (2023-2030) 5.4.1.3.1. Hospitals 5.4.1.3.2. Pharma & Biotech Companies 5.4.1.3.3. Clinical Laboratories 5.4.1.3.4. Others 5.4.2. Canada 5.4.2.1. Canada Immunoassay Market Size and Forecast, by Type (2023-2030) 5.4.2.1.1. Radioimmunoassay (RIA) 5.4.2.1.2. Enzyme Immunoassays (EIA) 5.4.2.1.3. Fluoroimmnoassay (FIA) 5.4.2.1.4. Chemiluminescence Immunoassay (CLIA) 5.4.2.1.5. Others 5.4.2.2. Canada Immunoassay Market Size and Forecast, by Application (2023-2030) 5.4.2.2.1. Disease Diagnosis 5.4.2.2.2. Therapeutic Drug Monitoring 5.4.2.2.3. Drug Discovery 5.4.2.2.4. Clinical Chemistry 5.4.2.2.5. Hematology 5.4.2.2.6. Others 5.4.2.3. Canada Immunoassay Market Size and Forecast, by End User (2023-2030) 5.4.2.3.1. Hospitals 5.4.2.3.2. Pharma & Biotech Companies 5.4.2.3.3. Clinical Laboratories 5.4.2.3.4. Others 5.4.3. Mexico 5.4.3.1. Mexico Immunoassay Market Size and Forecast, by Type (2023-2030) 5.4.3.1.1. Radioimmunoassay (RIA) 5.4.3.1.2. Enzyme Immunoassays (EIA) 5.4.3.1.3. Fluoroimmnoassay (FIA) 5.4.3.1.4. Chemiluminescence Immunoassay (CLIA) 5.4.3.1.5. Others 5.4.3.2. Mexico Immunoassay Market Size and Forecast, by Application (2023-2030) 5.4.3.2.1. Disease Diagnosis 5.4.3.2.2. Therapeutic Drug Monitoring 5.4.3.2.3. Drug Discovery 5.4.3.2.4. Clinical Chemistry 5.4.3.2.5. Hematology 5.4.3.2.6. Others 5.4.3.3. Mexico Immunoassay Market Size and Forecast, by End User (2023-2030) 5.4.3.3.1. Hospitals 5.4.3.3.2. Pharma & Biotech Companies 5.4.3.3.3. Clinical Laboratories 5.4.3.3.4. Others 6. Europe Immunoassay Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 6.1. Europe Immunoassay Market Size and Forecast, by Type (2023-2030) 6.2. Europe Immunoassay Market Size and Forecast, by Application (2023-2030) 6.3. Europe Immunoassay Market Size and Forecast, by End User (2023-2030) 6.4. Europe Immunoassay Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Immunoassay Market Size and Forecast, by Type (2023-2030) 6.4.1.2. United Kingdom Immunoassay Market Size and Forecast, by Application (2023-2030) 6.4.1.3. United Kingdom Immunoassay Market Size and Forecast, by End User (2023-2030) 6.4.2. France 6.4.2.1. France Immunoassay Market Size and Forecast, by Type (2023-2030) 6.4.2.2. France Immunoassay Market Size and Forecast, by Application (2023-2030) 6.4.2.3. France Immunoassay Market Size and Forecast, by End User (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Immunoassay Market Size and Forecast, by Type (2023-2030) 6.4.3.2. Germany Immunoassay Market Size and Forecast, by Application (2023-2030) 6.4.3.3. Germany Immunoassay Market Size and Forecast, by End User (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Immunoassay Market Size and Forecast, by Type (2023-2030) 6.4.4.2. Italy Immunoassay Market Size and Forecast, by Application (2023-2030) 6.4.4.3. Italy Immunoassay Market Size and Forecast, by End User (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Immunoassay Market Size and Forecast, by Type (2023-2030) 6.4.5.2. Spain Immunoassay Market Size and Forecast, by Application (2023-2030) 6.4.5.3. Spain Immunoassay Market Size and Forecast, by End User (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Immunoassay Market Size and Forecast, by Type (2023-2030) 6.4.6.2. Sweden Immunoassay Market Size and Forecast, by Application (2023-2030) 6.4.6.3. Sweden Immunoassay Market Size and Forecast, by End User (2023-2030) 6.4.7. Russia 6.4.7.1. Russia Immunoassay Market Size and Forecast, by Type (2023-2030) 6.4.7.2. Russia Immunoassay Market Size and Forecast, by Application (2023-2030) 6.4.7.3. Russia Immunoassay Market Size and Forecast, by End User (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Immunoassay Market Size and Forecast, by Type (2023-2030) 6.4.8.2. Rest of Europe Immunoassay Market Size and Forecast, by Application (2023-2030) 6.4.8.3. Rest of Europe Immunoassay Market Size and Forecast, by End User (2023-2030) 7. Asia Pacific Immunoassay Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 7.1. Asia Pacific Immunoassay Market Size and Forecast, by Type (2023-2030) 7.2. Asia Pacific Immunoassay Market Size and Forecast, by Application (2023-2030) 7.3. Asia Pacific Immunoassay Market Size and Forecast, by End User (2023-2030) 7.4. Asia Pacific Immunoassay Market Size and Forecast, by Industry (2023-2030) 7.5. Asia Pacific Immunoassay Market Size and Forecast, by Country (2023-2030) 7.5.1. China 7.5.1.1. China Immunoassay Market Size and Forecast, by Type (2023-2030) 7.5.1.2. China Immunoassay Market Size and Forecast, by Application (2023-2030) 7.5.1.3. China Immunoassay Market Size and Forecast, by End User (2023-2030) 7.5.2. S Korea 7.5.2.1. S Korea Immunoassay Market Size and Forecast, by Type (2023-2030) 7.5.2.2. S Korea Immunoassay Market Size and Forecast, by Application (2023-2030) 7.5.2.3. S Korea Immunoassay Market Size and Forecast, by End User (2023-2030) 7.5.3. Japan 7.5.3.1. Japan Immunoassay Market Size and Forecast, by Type (2023-2030) 7.5.3.2. Japan Immunoassay Market Size and Forecast, by Application (2023-2030) 7.5.3.3. Japan Immunoassay Market Size and Forecast, by End User (2023-2030) 7.5.4. India 7.5.4.1. India Immunoassay Market Size and Forecast, by Type (2023-2030) 7.5.4.2. India Immunoassay Market Size and Forecast, by Application (2023-2030) 7.5.4.3. India Immunoassay Market Size and Forecast, by End User (2023-2030) 7.5.5. Australia 7.5.5.1. Australia Immunoassay Market Size and Forecast, by Type (2023-2030) 7.5.5.2. Australia Immunoassay Market Size and Forecast, by Application (2023-2030) 7.5.5.3. Australia Immunoassay Market Size and Forecast, by End User (2023-2030) 7.5.6. ASEAN 7.5.6.1. ASEAN Immunoassay Market Size and Forecast, by Type (2023-2030) 7.5.6.2. ASEAN Immunoassay Market Size and Forecast, by Application (2023-2030) 7.5.6.3. ASEAN Immunoassay Market Size and Forecast, by End User (2023-2030) 7.5.7. Rest of Asia Pacific 7.5.7.1. Rest of Asia Pacific Immunoassay Market Size and Forecast, by Type (2023-2030) 7.5.7.2. Rest of Asia Pacific Immunoassay Market Size and Forecast, by Application (2023-2030) 7.5.7.3. Rest of Asia Pacific Immunoassay Market Size and Forecast, by End User (2023-2030) 8. Middle East and Africa Immunoassay Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 8.1. Middle East and Africa Immunoassay Market Size and Forecast, by Type (2023-2030) 8.2. Middle East and Africa Immunoassay Market Size and Forecast, by Application (2023-2030) 8.3. Middle East and Africa Immunoassay Market Size and Forecast, by End User (2023-2030) 8.4. Middle East and Africa Immunoassay Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Immunoassay Market Size and Forecast, by Type (2023-2030) 8.4.1.2. South Africa Immunoassay Market Size and Forecast, by Application (2023-2030) 8.4.1.3. South Africa Immunoassay Market Size and Forecast, by End User (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Immunoassay Market Size and Forecast, by Type (2023-2030) 8.4.2.2. GCC Immunoassay Market Size and Forecast, by Application (2023-2030) 8.4.2.3. GCC Immunoassay Market Size and Forecast, by End User (2023-2030) 8.4.3. Rest of ME&A 8.4.3.1. Rest of ME&A Immunoassay Market Size and Forecast, by Type (2023-2030) 8.4.3.2. Rest of ME&A Immunoassay Market Size and Forecast, by Application (2023-2030) 8.4.3.3. Rest of ME&A Immunoassay Market Size and Forecast, by End User (2023-2030) 9. South America Immunoassay Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030 9.1. South America Immunoassay Market Size and Forecast, by Type (2023-2030) 9.2. South America Immunoassay Market Size and Forecast, by Application (2023-2030) 9.3. South America Immunoassay Market Size and Forecast, by End User (2023-2030) 9.4. South America Immunoassay Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Immunoassay Market Size and Forecast, by Type (2023-2030) 9.4.1.2. Brazil Immunoassay Market Size and Forecast, by Application (2023-2030) 9.4.1.3. Brazil Immunoassay Market Size and Forecast, by End User (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Immunoassay Market Size and Forecast, by Type (2023-2030) 9.4.2.2. Argentina Immunoassay Market Size and Forecast, by Application (2023-2030) 9.4.2.3. Argentina Immunoassay Market Size and Forecast, by End User (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Immunoassay Market Size and Forecast, by Type (2023-2030) 9.4.3.2. Rest Of South America Immunoassay Market Size and Forecast, by Application (2023-2030) 9.4.3.3. Rest Of South America Immunoassay Market Size and Forecast, by End User (2023-2030) 10. Company Profile: Key Players 10.1. Siemens Healthineers 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Becton 10.3. Dickinson & Company 10.4. BioMérieux 10.5. Abbott laboratories 10.6. Roche Diagnostics 10.7. Danaher Corporation 10.8. Ortho Clinical Diagnostics 10.9. Sysmex Corporation 10.10. Thermo Fisher Scientific, Inc. 10.11. Quidel Corporation 10.12. Agilent Technologies 10.13. PerkinElmer 10.14. Mindray 10.15. DiaSorin 11. Key Findings & Analyst Recommendations 12. Immunoassay Market: Research Methodology 12.1.1. Top-Down Approach 12.1.2. Bottom-up Approach
